Page last updated: 2024-08-17

aspartic acid and Coxsackie Virus Infections

aspartic acid has been researched along with Coxsackie Virus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, L; Gu, J; Huang, C; Kong, Q; Lin, D; Lu, R; Wu, W1
Berkley, N; Huber, S; Jeon, ES; Knowlton, KU; Wessely, R1

Other Studies

2 other study(ies) available for aspartic acid and Coxsackie Virus Infections

ArticleYear
NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.
    Molecules (Basel, Switzerland), 2022, Sep-19, Volume: 27, Issue:18

    Topics: Alanine; Animals; Aspartic Acid; Biomarkers; Cardiomyopathy, Dilated; Coxsackievirus Infections; Enterovirus B, Human; Glutamic Acid; Glutamine; Glycine; Mice; Mice, Inbred BALB C; Myocarditis; Niacin; Niacinamide; Serine; Taurine; Threonine

2022
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Journal of virology, 1996, Volume: 70, Issue:11

    Topics: Animals; Aspartic Acid; Base Sequence; Capsid; Capsid Proteins; Cloning, Molecular; COS Cells; Coxsackievirus Infections; DNA, Complementary; DNA, Viral; Enterovirus B, Human; Genetic Variation; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation; Myocarditis; Phenotype

1996